September 20th, 2017
At Mayo Clinic, research is integral to everything we do. We would be unable to offer the highest possible levels of care and continually improve the practice of medicine without research, and the education programs and processes to make it a reality. We are pleased to introduce some of our newest programs – or in […]
September 19th, 2017
Karter Malcomson coos and swivels his head when he hears his name in his mother’s reassuring voice. “You know we’re talking about you, don’t you?” Karter’s mom, Kerrie, says. “Karter is a very happy boy. He’s very content. He’s very interested in everything, especially people. He’s definitely a people person.” His father, Zane, spins Karter […]
Tags: C2CD3, Center for Individualized Medicine, Charu Kaiwar, Department of Clinical Genomics, Eric Klee, Filippo Pinto e Vairo, genetic disorder, Karter Malcomson, Margot Cousin, molecular geneticist, Nicole Boczek, oral-facial-digital syndrome type 14
September 7th, 2017
Muneer Satter’s first interest in medicine wasn’t rooted in genomics. It was in seeing the health care needs of his loved ones and of the world’s most vulnerable. In his professional life, before making investments in biotech, he sought out the opinions of expert doctors at Mayo Clinic. “The more I talked to doctors, the […]
August 24th, 2017
Families living with Alzheimer’s disease woke to devastating newspaper headlines recently: Another highly touted drug failed in clinical trials. Drugmaker Eli Lilly’s EXPEDITION3 trial tested an antibody, a molecule used by the immune system to fight off disease, called solanezumab. This experimental drug sought to remove harmful proteins in the brain that become building blocks for amyloid, […]
Tags: Alzheimer's, Alzheimer's Disease Research Center, amyloid protein, dementia, Mayo Clinic Robert and Arlene Kogod Center on Aging, Mayo Clinic Study of Aging, research, Rochester Epidemiology Project, Ronald Petersen, tau
August 15th, 2017
Allan B. Dietz, Ph.D., never intended to be a scientist. His plan was to be a farmer, just like his father, grandfather and all the other Dietzes he knew. “I was going to be a farmer at first. Then I was going to be a veterinarian because that’s what farm kids who like science did,” […]
Tags: Alan Dietz, ALS, Amyotrophic lateral sclerosis, Center for Regenerative Medicine, Department of Laboratory Medicine and Pathology, DLMP, FDA, Food and Drug Administration, Lou Gehrig's disease, Mayo Clinic Cancer Center, mesenchymal cells, research
August 10th, 2017
Mayo Clinic’s Center for Individualized Medicine is collaborating with a molecular diagnostics company to monitor patients after an organ transplant and improve the efficacy of immunosuppressant drugs by tailoring treatment to an individual’s genome. The effectiveness of immunosuppressant drugs is governed by a number of factors, but a major contributor is an individual’s genome. The […]
August 3rd, 2017
For decades, the emphasis nationwide for treating surgical patients was to prescribe enough opioid pain medication to ensure they didn’t have any pain. But health care providers are realizing it’s a balancing act between managing pain and ensuring patients aren’t overprescribed.
Tags: Dr. Cornelius Thiels, Dr. Elizabeth Habermann, Dr. Robert Cima, Dr. Tad Mabry, Kern Center, Kern Center for the Science of Health Care Delivery, Mayo Clinic research, Mayo Clinic School of Graduate Medical Education, medical research, narcotic, opioid, opioid drugs
July 27th, 2017
At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this video, Kristin R. Swanson, Ph.D., a brain cancer researcher at Mayo Clinic’s campus in Phoenix, Arizona, discusses her research. This article originally appeared in Forefront, Mayo Clinic Cancer […]
July 18th, 2017
Forefront is the complimentary magazine of the Mayo Clinic Cancer Center. Published in print and online magazine editions annually and in email and online newsletter editions quarterly, Forefront highlights Mayo Clinic’s cutting-edge cancer research and the latest Cancer Center news. View the online edition. View the email newsletter. Subscribe.
June 28th, 2017
With colon cancer, some earlier stage patients fare worse than some later stage patients, who usually benefit most from chemotherapy. But a research team at Mayo Clinic has discovered that a simple blood test could help determine which patients are at a higher risk and therefore could benefit from therapy. The researchers also found many patients who could benefit from the test likely aren’t receiving it.